Article
Implementation of next-generation sequencing for molecular diagnosis of hereditary breast and ovarian cancer highlights its genetic heterogeneity.
Breast cancer research and treatment - 1 Sept 2016
Pinto Pedro, Paulo Paula, Santos Catarina, Rocha Patrícia, Pinto Carla, Veiga Isabel, Pinheiro Manuela, Peixoto Ana, Teixeira Manuel R
Abstract excerpt
Molecular diagnosis of hereditary breast and ovarian cancer (HBOC) by standard methodologies has been limited to the BRCA1 and BRCA2 genes. With the recent development of new sequencing methodologies, the speed and efficiency of DNA testing have dramatically improved. The aim of this work was to validate the use of next-generation sequencing (NGS) for the detection of BRCA1/BRCA2 point mutations in a diagnostic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
